Navigating the evolving landscape of primary hyperoxaluria: Traditional management defied by the rise of novel molecular drugs

Y Huang, W Zhu, J Zhou, Q Huang, G Zeng - Biomolecules, 2024 - mdpi.com
Primary hyperoxalurias (PHs) are inherited metabolic disorders marked by enzymatic
cascade disruption, leading to excessive oxalate production that is subsequently excreted in …

Medical and dietary interventions for preventing recurrent urinary stones in children

A Kern, G Grimsby, H Mayo… - Cochrane Database of …, 2017 - cochranelibrary.com
Background Nephrolithiasis, or urinary stone disease, in children causes significant
morbidity, and is increasing in prevalence in the North American population. Therefore …

Mechanistic pathways for the molecular step growth of calcium oxalate monohydrate crystal revealed by in situ liquid-phase atomic force microscopy

KR Cho, JH Lee, HS Seo, Y Ji, JH Park… - … Applied Materials & …, 2021 - ACS Publications
Calcium oxalate monohydrate (COM) crystal is the most common crystalline component of
human kidney stones. The molecular-scale inhibitory mechanisms of COM crystal growth by …

[HTML][HTML] Effect of urine pH and magnesium on calcium oxalate saturation

S Ferrè, JS Grange, B Adams-Huet, OW Moe… - Magnesium research, 2017 - jle.com
Background. Hypomagnesiuria is a common biochemical finding in patients with calcium
oxalate (CaOx) nephrolithiasis. Clinical trials using Mg supplements as therapy against …

Evaluation of the effects of magnesium supplement in primary and secondary preventions of nephrolithiasis: a systematic review.

A Azarfar, M Esmaeili, N Tousi… - Reviews in Clinical …, 2016 - search.ebscohost.com
Introduction: The role of magnesium supplement to prevent primary and/or secondary kidney
stones has not been fully determined. The aim of this study is to evaluate the effects of …

Evaluating the effectiveness of adding magnesium chloride to conventional protocol of citrate alkali therapy on kidney stone size

H Niroomand, A Ziaee, K Ziaee… - Advanced biomedical …, 2016 - journals.lww.com
Background: Potassium citrate (K-Cit) is one of the therapeutic solutions broadly used in
patients with urolithiasis. However, recent studies have shown that it is not so effective …

[HTML][HTML] Оценка влияния степени экскреции фосфатов и магния на частоту формирования мочевых камней различного химического состава

МЮ Просянников, НВ Анохин… - Экспериментальная …, 2020 - cyberleninka.ru
Введение. Заболеваемость МКБ неуклонно растет практически во всех регионах мира,
в том числе и в Российской Федерации. Изучение метаболизма веществ …

[HTML][HTML] Prevention of recurrence

NGC UK - 2019 - ncbi.nlm.nih.gov
It is estimated that about one third of people affected by renal and ureteric stones will
experience a recurrence at five years without treatment of the underlying cause. This rate of …

[CITÁCIA][C] Efficacy of Alkali Citrate Salts in the Prevention of Kidney Stone Formation

DS Goldfarb, A Sholder - 2020